ArticleBMC nutrition2026
Challenges, motivators and coping strategies of iron-folic acid tablets intake in the girls iron-folic acid tablet supplementation program in Wa municipality of Ghana.
Article in BMC nutrition, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundThe World Health Organization has recommended intermittent weekly iron-folic acid (IFA) supplementation as the most cost-effective intervention to reduce the burden of anemia among adolescents and women in child bearing age. Given the documented benefits of iron-folic acid supplementation, it goes with jurisdictional hurdles and motivators for uptake yet little is known in this regard in our study's settings. This study aimed to assess the challenges, motivators, and coping strategies for IFA tablets intake among beneficiaries in the Girls Iron-Folic Acid Tablet Supplementation (GIFTS) program of the Upper West region-Ghana. MATERIALS AND
methodsA convergent parallel mixed-methods design (n = 355; three focus group discussions) was used in this study. Semi-structured questionnaire was used to gather data on socio-demographic characteristics, motivators for IFA tablets intake, while focus group discussion was used to collect data on challenges, motivators and coping strategies for IFA tablets intake.
resultsChallenges to IFA tablets intake were reported under personal level (pharmacophobia, inadequate knowledge, experienced side effects, and forgetfulness), product level (negative sensory attributes), and school/distribution level (distribution failures and shortages). IFA tablets intake was motivated by perceived personal level benefits (nutritional and health benefits, appetite enhancement, menstrual benefits) derived from the IFA up-take. Participants adopted various coping strategies for personal and product level challenges, (Water therapy, massage therapy, medication, rest/reduced mobility, changed dressing style, avoiding tablets intake, and masking of tablets). The study also showed that participants had no specific coping mechanism for school/distribution level challenges (distribution failures and shortages).
conclusionVaried challenges, motivators, and coping strategies for IFA intake were identified. Beneficiaries experienced shortages of IFA tablets distribution. It is thus recommended that implementers of the GIFTS program make the tablets readily available to schools to avoid shortages.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.